首页 正文

A new FLT3 inhibitor with two cases: the gilteritinib experience

{{output}}
Introduction: In acute myeloid leukemia (AML), a heterogeneous group of leukemias, there are various factors to determine prognosis. Among these prognostic factors, cytogenetic results are increasing in importance day by day. FLT... ...